Takeda gets approval for acute lymphoblastic leukemia treatment sNDA

The study compared the efficacy and safety of ICLUSIG plus low intensity chemotherapy against imatinib plus chemotherapy in 245 subjects. Credit: fernando zhiminaicela from Pixabay.